These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 32044352)

  • 21. Inhibition of TLR4 signalling to dampen joint inflammation in osteoarthritis.
    Bartels YL; van Lent PLEM; van der Kraan PM; Blom AB; Bonger KM; van den Bosch MHJ
    Rheumatology (Oxford); 2024 Mar; 63(3):608-618. PubMed ID: 37788083
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mitochondrial Damage-Associated Molecular Patterns: From Inflammatory Signaling to Human Diseases.
    Grazioli S; Pugin J
    Front Immunol; 2018; 9():832. PubMed ID: 29780380
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of innate immunity in osteoarthritis: when our first line of defense goes on the offensive.
    Orlowsky EW; Kraus VB
    J Rheumatol; 2015 Mar; 42(3):363-71. PubMed ID: 25593231
    [TBL] [Abstract][Full Text] [Related]  

  • 24. DAMP-sensing receptors in sterile inflammation and inflammatory diseases.
    Gong T; Liu L; Jiang W; Zhou R
    Nat Rev Immunol; 2020 Feb; 20(2):95-112. PubMed ID: 31558839
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interleukin 33: an innate alarm for adaptive responses beyond Th2 immunity-emerging roles in obesity, intestinal inflammation, and cancer.
    Schwartz C; O'Grady K; Lavelle EC; Fallon PG
    Eur J Immunol; 2016 May; 46(5):1091-100. PubMed ID: 27000936
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of Inflammation and the Immune System in the Progression of Osteoarthritis.
    Woodell-May JE; Sommerfeld SD
    J Orthop Res; 2020 Feb; 38(2):253-257. PubMed ID: 31469192
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Specialised lipid mediators and their targets.
    Crean D; Godson C
    Semin Immunol; 2015 May; 27(3):169-76. PubMed ID: 26048571
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting of chondrocyte plasticity via connexin43 modulation attenuates cellular senescence and fosters a pro-regenerative environment in osteoarthritis.
    Varela-Eirín M; Varela-Vázquez A; Guitián-Caamaño A; Paíno CL; Mato V; Largo R; Aasen T; Tabernero A; Fonseca E; Kandouz M; Caeiro JR; Blanco A; Mayán MD
    Cell Death Dis; 2018 Dec; 9(12):1166. PubMed ID: 30518918
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeting chronic innate inflammatory pathways, the main road to prevention of osteoarthritis progression.
    Herrero-Beaumont G; Pérez-Baos S; Sánchez-Pernaute O; Roman-Blas JA; Lamuedra A; Largo R
    Biochem Pharmacol; 2019 Jul; 165():24-32. PubMed ID: 30825432
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Danger-Associated Molecular Patterns Derived From the Extracellular Matrix Provide Temporal Control of Innate Immunity.
    Frevert CW; Felgenhauer J; Wygrecka M; Nastase MV; Schaefer L
    J Histochem Cytochem; 2018 Apr; 66(4):213-227. PubMed ID: 29290139
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cellular senescence in osteoarthritis pathology.
    McCulloch K; Litherland GJ; Rai TS
    Aging Cell; 2017 Apr; 16(2):210-218. PubMed ID: 28124466
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aging-related inflammation in osteoarthritis.
    Greene MA; Loeser RF
    Osteoarthritis Cartilage; 2015 Nov; 23(11):1966-71. PubMed ID: 26521742
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tissue-specific pathways extrude activated ILC2s to disseminate type 2 immunity.
    Ricardo-Gonzalez RR; Schneider C; Liao C; Lee J; Liang HE; Locksley RM
    J Exp Med; 2020 Apr; 217(4):. PubMed ID: 32031571
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Toll-like receptors and their soluble forms differ in the knee and thumb basal osteoarthritic joints.
    Barreto G; Sandelin J; Salem A; Nordström DC; Waris E
    Acta Orthop; 2017 Jun; 88(3):326-333. PubMed ID: 28093922
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-alarmin approaches entering clinical trials.
    Gauvreau GM; White L; Davis BE
    Curr Opin Pulm Med; 2020 Jan; 26(1):69-76. PubMed ID: 31408015
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synovial inflammation, immune cells and their cytokines in osteoarthritis: a review.
    de Lange-Brokaar BJ; Ioan-Facsinay A; van Osch GJ; Zuurmond AM; Schoones J; Toes RE; Huizinga TW; Kloppenburg M
    Osteoarthritis Cartilage; 2012 Dec; 20(12):1484-99. PubMed ID: 22960092
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interleukin-1β signaling in osteoarthritis - chondrocytes in focus.
    Jenei-Lanzl Z; Meurer A; Zaucke F
    Cell Signal; 2019 Jan; 53():212-223. PubMed ID: 30312659
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human Inflammaging.
    Fülöp T; Larbi A; Witkowski JM
    Gerontology; 2019; 65(5):495-504. PubMed ID: 31055573
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synergistic anabolic actions of hyaluronic acid and platelet-rich plasma on cartilage regeneration in osteoarthritis therapy.
    Chen WH; Lo WC; Hsu WC; Wei HJ; Liu HY; Lee CH; Tina Chen SY; Shieh YH; Williams DF; Deng WP
    Biomaterials; 2014 Dec; 35(36):9599-607. PubMed ID: 25176059
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immune-Neuroendocrine Dysregulation in Patients with Osteoarthritis: A Revision and a Pilot Study.
    Galvez I; Torres-Piles S; Hinchado MD; Alvarez-Barrientos A; Torralbo-Jimenez P; Guerrero J; Martin-Cordero L; Ortega E
    Endocr Metab Immune Disord Drug Targets; 2017; 17(1):78-85. PubMed ID: 28322172
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.